1National Cholesterol Education Program(NCEP) Expert Panel on Detec tion, Evaluation, and Treatment of High Blood Cholesterol in Adults ( Adult Tteatment Panel Ⅲ ) . Third Report of the National Cholosterol Ed ucation Program (NCEP)Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults( Adult Tteatment Panel Ⅲ ) final report [J]. Circulation, 2002,106 (25): 3143.
2Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the national cholesterol education program Adult Treatment Panel Ⅲ guidelines[J]. Circulation,2004,110(2) :227.
3Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial [J]. Lancet, 2002,360(9346): 1623.
4Sever PS, Dahlof B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the anglo-scandinavian cardiac outcomes trial-lipid lowering arm (ASCOT-LLA) :a multicentre randomised controlled trial [J]. Lancet, 2003,361 ( 9364 ): 1149.
5Collins R, Armitage J, Parish S, et al. Effects on cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions[J]. Lancet, 2004,363(9411) :757.
6Nissen SE, Tuzcu EM, Schoenhagen P, et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial[J]. JAMA, 2004,291 (9): 1071.
7Cannon CP, Braunwald E, MaCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes[J]. N Engl J Med.2004,350(15): 1495.
8LaRosa JC, Grundy SM, Waters DDE, et al. Intensive lipid lowering withatorvastatin in patients with stable coronary disease[J]. N Engl J Med, 2005,352(14): 1425.
9Grundy SM.The issue of statin safety:where do we stand? [J]. Circulation, 2005,111 (23): 3016.
10De Iemos JA, Blazing MA, Wiviott SD, et al. Early intensive vs a de layed conservative simvastatin strategy in patients with acute coronary syndromes:phase Z of the A to Z trial[J] . JAMA, 2004, 292( 11 ):1307.
